 |
CREDENTIALS
Fayaz
Shawl, MD, FACP, FCCP, FACC
Dr.
Shawl is currently the Director of Interventional
Cardiology at Washington Adventist Hospital in Takoma
Park, Maryland, as well as Professor and Director
of Interventional Cardiovascular Medicine at George
Washington University School of Medicine in Washington,
D.C., USA.
Dr.
Shawl received his medical degree from Kashmir Medical
College in 1972 and completed his residency in England.
In
1977, Dr. Shawl moved to the United States and completed
his cardiology fellowship at The Walter Reed Army
Medical Center. Dr. (Maj.) Shawl brought the military
into the balloon age when he performed the first
PTCA in the United States Military
(Army, Navy, Air Force) at Walter Reed Army Medical
Center in 1980. Between 1979 and 2003, Dr. Shawl retained
clinical appointments at Georgetown University School
of Medicine, George Washington University School of
Medicine and the Uniformed Services University School
of Medicine, while developing leadership roles in
Interventional Cardiology at both Washington Adventist
Hospital and George Washington University Hospital.
Dr.
Shawl is a member of the American College of Physicians,
the Royal College of Physicians of the United Kingdom,
General Medical Council of the United Kingdom, the
American Medical Association and American Heart Association.
He is a Fellow of the American College of Cardiology,
the American College of Chest Physicians, American
College of Physicians, the American College of Angiology
and The Society for Cardiac Angiography and Interventions.
Dr.
Shawl has played an active role in all aspects of
Interventional Cardiology ever since he performed
the first PTCA at Walter Reed Army Medical Center
in 1981. While he has lectured widely on every topic
of Interventional Cardiology, he has been a
leading proponent and innovator in the development
of the percutaneous approach (known as Shawl Technique)
to cardiopulmonary bypass support in "High Risk Angioplasty
and Cardiac Arrest" performing the first percutaneous
bypass-supported coronary intervention in the world
in 1988. This technology is truly a lifesaver and
when available in the Cardiac Catheterization Laboratory,
complications leading to death would be impossible.
Since its invention in 1988, there has not been a
single death in the Cardiac Catheterization Laboratory
at Washington Adventist while Dr. Shawl performed
coronary interventions. He has lectured on this topic
and trained physicians through out the world. In a
study involving 23,472 patients undergoing elective
coronary interventions at Washington Adventist Hospital
using percutaneous CPS standby rather than formal
surgical backup for elective coronary interventions,
resulted in NO deaths during the procedure. However,
39 patients (0.2%) did develop refractory hemodynamic
collapse (imminent death) during which emergency CPS
was instituted within 12 minutes. Of these 39 patients,
31 patients were discharged from the hospital (Shawl,
et al. JACC 2001; 37(2A), 175A).
He
has been teaching through live demonstrations other
techniques of interventional cardiology (including
coronary, carotid and other peripheral and non-cardiac
interventions like valvuloplasty, ablative technique
for IHSS, etc.) here at Washington Adventist Hospital
from 1987 - 1998 and all over the world. Such types
of teaching seminars are done through satellite or
local broadcast live from the CATH lab.
A
true innovator in working with the high risk patient,
Dr. Shawl was the first Interventional
Cardiologist to use both the Eclipse Holmium Laser
as well as the AngioTrax mechanical device (1999)
for Percutaneous Transluminal Myocardial Revascularization
in the investigational treatment of end-stage atherosclerotic
heart disease (patients with no options). He did both
procedures as part of research first in world at New
Delhi, India. He was also first to perform mitral
valvuloplasty in the Washington, DC metropolitan area
in 1985.
Dr.
Shawl is a member of the renowned International Gruentzig
Society and was recognized as one of the world's most
talented interventionists in an interview for the
Journal of Invasive Cardiology in April 2001 (JIC,
Vol. 13, No. 4, April 2001). He was acknowledged to
have performed the most interventional
procedures as a single operator (over 19,000) than
any other interventionist in the world.
Currently
in pursuit of stroke prevention, the number two cause
of death, Dr. Shawl and others have pioneered the
technique of carotid artery stenting. He performed
the first percutaneous carotid
artery stenting in this region in 1995.
The results of this new avenue of endovascular therapy
may challenge the accepted practice of surgical carotid
endarterectomy. Having done over 600 carotid stent
cases at Washington Adventist Hospital, using present
technique, what he calls "meticulous technique" has
resulted in a complication rate of <0.5% in the last
300 cases.
Dr.
Shawl has a very active, accredited interventional
fellowship program at Washington Adventist Hospital
in association with the program at George Washington
University Hospital in Washington, D.C. Out of 179
available interventional training positions throughout
the US, he has three positions in his interventional
program.
Dr.
Shawl has authored over 150 leading articles, abstracts,
editorials and book chapters. He has also published
a book entitled "Supported Complex and High Risk Coronary
Angioplasty". Some of his more recent awards include
the dedication of the Fayaz
Shawl Advanced Interventional Catheterization Laboratory
at Washington Adventist Hospital in 1998, 2002
Innovators Award from the Alliance
of Cardiovascular Professionals, as well as several
recognition awards from the Maryland State Senate
and the United States House of Representatives. Dr.
Shawl received nomination as
International Health Professional of the Year (2003).
This prestigious award is given to individuals whose
achievements and leadership stand out in the International
Community as decreed by the Research and Advisory
Board sitting at the International Biographical Center
in Cambridge, England. Dr. Shawl is also the only
physician to be interviewed by Insight On The News
Magazine, click
here to read the article.
Srinagar
in Kashmir, India, the birth place of Dr. Shawl,
will be the locale for the first cardiac specialty
hospital. (see
pictures of Kashmir) Dr. Shawl is very keen to
give practical shape to his vision of “good health”
for the Kashmiri people. He is in the process of finalizing
the purchase of a plot of land in the foothills of
the Zabarwan range near the picturesque Nishat Garden
area. The
Dr. Fayaz Shawl Philanthropic Foundation Inc.
intends to build a 50-bed cardiac specialty hospital
along with a cardiac wellness Center on this land.
This Cardiac wellness center will educate and promote
healthy living habits, which is essential in the prevention
of heart disease. After the completion of this Center,
The Foundation plans to set up additional cardiac
specialty hospitals in other areas of the world, including
Washington, D.C. These cardiac specialty centers will
treat the underprivileged at no cost regardless of
the patient's ethnicity, religious preference, or
country of origin. However, there will charges to
those who can afford to pay for these highly specialized
quality services.
Further
universal areas of interest to be considered, submitted
by our internet audience and is encouraged for selection
of similar laboratories to be erected.
|
|
